PA

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chrysochou C et al. – No study to our knowledge has looked at both NT–proBNP and cTnT as outcome markers in ARVD. The study shows that renal function is more important as a marker of suffering a CVE. However, raised NT–proBNP is associated with a greater likelihood of death when subdivided by CKD stage. Early risk stratification by simple measurement of these biomarkers may aid in intensifying management in high–risk patients, although further studies to assess the value of this approach are warranted.

Related Articles

Imaging in the evaluation of renovascular disease
Pediatric Nephrology, 10/28/09    Relevance Score: 66%

Atherosclerotic renovascular disease in the United States
Kidney International, 10/30/09    Relevance Score: 65%

Revascularization versus Medical Therapy for Renal-Artery Stenosis
New England Journal of Medicine, 11/12/09    Relevance Score: 64%

Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience
Nephrology Dialysis Transplantation, 10/30/09    Relevance Score: 64%

Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension
Pediatric Nephrology, 10/28/09    Relevance Score: 64%

Today in Cardiology...keeping you current

Does This Patient With Palpitations Have a Cardiac Arrhythmia
JAMA, 11/24/09

Acute Treatment of ST-Segment-Elevation Myocardial Infarction: Is There a Role for the Cardiac Surgeon
Annals of Thoracic Surgery, 11/24/09

Understanding Omega-3 Polyunsaturated Fatty Acids
Postgraduate Medicine, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address